Mechanisms of PTEN loss in cancer: It's all about diversity
V Álvarez-Garcia, Y Tawil, HM Wise… - Seminars in cancer biology, 2019 - Elsevier
PTEN is a phosphatase which metabolises PIP 3, the lipid product of PI 3-Kinase, directly
opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly …
opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly …
[HTML][HTML] Excitotoxicity and stroke: identifying novel targets for neuroprotection
Excitotoxicity, the specific type of neurotoxicity mediated by glutamate, may be the missing
link between ischemia and neuronal death, and intervening the mechanistic steps that lead …
link between ischemia and neuronal death, and intervening the mechanistic steps that lead …
Multiplex assessment of protein variant abundance by massively parallel sequencing
Determining the pathogenicity of genetic variants is a critical challenge, and functional
assessment is often the only option. Experimentally characterizing millions of possible …
assessment is often the only option. Experimentally characterizing millions of possible …
The PTEN–PI3K pathway: of feedbacks and cross-talks
The tumor suppressor PTEN was originally identified as a negative regulator of the
phosphoinositide 3-kinase (PI3K) signaling, a main regulator of cell growth, metabolism and …
phosphoinositide 3-kinase (PI3K) signaling, a main regulator of cell growth, metabolism and …
PTEN function: the long and the short of it
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a phosphatase that
is frequently altered in cancer. PTEN has phosphatase-dependent and-independent roles …
is frequently altered in cancer. PTEN has phosphatase-dependent and-independent roles …
PTEN tumor suppressor network in PI3K-Akt pathway control
MM Georgescu - Genes & cancer, 2010 - journals.sagepub.com
The PI3K-Akt pathway is a major survival pathway activated in cancer. Efforts to develop
targeted therapies have not been fully successful, mainly because of extensive internal …
targeted therapies have not been fully successful, mainly because of extensive internal …
Ubiquitination regulates PTEN nuclear import and tumor suppression
The PTEN tumor suppressor is frequently affected in cancer cells, and inherited PTEN
mutation causes cancer-susceptibility conditions such as Cowden syndrome. PTEN acts as …
mutation causes cancer-susceptibility conditions such as Cowden syndrome. PTEN acts as …
The membrane surface as a platform that organizes cellular and biochemical processes
Membranes are essential for life. They act as semi-permeable boundaries that define cells
and organelles. In addition, their surfaces actively participate in biochemical reaction …
and organelles. In addition, their surfaces actively participate in biochemical reaction …
The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells
Exosomes are microvesicles of endosomal origin that are secreted, and their contents
(proteins, lipids, DNA, or microRNAs) can alter the physiological states of recipient cells. We …
(proteins, lipids, DNA, or microRNAs) can alter the physiological states of recipient cells. We …
Protein kinases and phosphatases in the control of cell fate
Protein phosphorylation controls many aspects of cell fate and is often deregulated in
pathological conditions. Several recent findings have provided an intriguing insight into the …
pathological conditions. Several recent findings have provided an intriguing insight into the …